Ortopedia_Oncologica_México

Ortopedia_Oncologica_México
Dr Ernesto Delgado Cedillo

sábado, 11 de agosto de 2012

Low-Grade Central Osteosarcoma: A Difficult Condition to Diagnose


Fuente: Hindawi Publishing Corporation
http://www.hindawi.com/journals/srcm/2012/764796/
Sarcoma
Volume 2012 (2012), Article ID 764796, 7 pages
doi:10.1155/2012/764796
Research Article

Low-Grade Central Osteosarcoma: A Difficult Condition to Diagnose

The Royal Orthopaedic Hospital Oncology Service, Royal Orthopaedic Hospital, Bristol Road South, Birmingham B31 2AP, UK
Received 13 March 2012; Accepted 23 May 2012
Academic Editor: H. Gelderblom
Copyright © 2012 A. M. Malhas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Low-grade central osteosarcoma (LGCO) is a rare variant of osteosarcoma which is difficult to diagnose. If not treated appropriately, the tumour can recur with higher-grade disease. We reviewed our experience of this condition to try and identify factors that could improve both diagnosis and outcome. 18 patients out of 1540 osteosarcoma cases (over 25 years) had LGCO (1.2%). Only 11 patients (61%) were direct primary referrals. Almost 40% (7 of 18) cases were referred after treatment elsewhere when the diagnosis had not been made initially and all presented with local recurrence. Of the 11 who presented primarily, the first biopsy was diagnostic in only 6 (55%) cases. Of the remaining cases, up to three separate biopsies were required before a definitive diagnosis was made. Overall survivorship at 5 years was 90%. 17 patients were treated with limb salvage procedures, and one patient had an amputation. The diagnosis of LGCO remains challenging due to the relatively nonspecific radiological and histological findings. Since treatment of LGCO is so different to a benign lesion, accurate diagnosis is essential. Any difficult or nondiagnostic biopsies of solitary bone lesions should be referred to specialist tumour units for a second opinion.

No hay comentarios:

Publicar un comentario